The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for sotorasib (Amgen Australia Pty Ltd)
Active ingredients
sotorasib
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Film-coated tablet
Indication
Treatment of non-small cell lung cancer (NSCLC) with genetic KRAS G12C mutation
Therapeutic area
Oncology